Solutions

Olfactive Biosolutions is using proprietary formulations of food molecules to activate ectopic receptors in the body to replace pharmaceuticals and treat myriad diseases.

This approach promises the ability to bring health and wellness to large parts of the globe.  Food molecules are cheap and plentiful. We have been eating them for millennia.  Unlike pharmaceuticals, they have few side effects and can be consumed on a long-term basis.

Olfactory receptors (ORs) and taste receptors occur in the nose and tongue and allow us to smell and taste the world, sensing up to one trillion different tastes and smells.  These same receptors occur throughout the body, where they are generally referred to as ectopic receptors.  These ectopic receptors participate in diverse biological processes, including the regulation of glucose and lipid metabolism.

Ectopic ORs can regulate a variety of metabolic events including insulin secretion, glucagon secretion, fatty acid oxidation, lipogenesis, and thermogenesis. Understanding the physiological function and deciphering the olfactory recognition code by suitable ligands make ectopic ORs potential targets for treating many different diseases.

Protenx™ Health & Wellness Formulations
Olfactive Biosolutions' line of Protenx proprietary food formulations are designed to be added to food & beverage and consumer packaged goods products by the manufacturer, to induce physiologic benefits by activating the ectopic receptors in the gut, skin, lungs, blood, kidneys and elsewhere.  Protenx formulations will also be available direct to consumers as supplements beginning Q12025.

Our Protenx Weight Loss formulations induce secretion of GLP-1, or secretion of both GLP-1 and GIP.

The Protenx line of proprietary food formulations now includes Protenx Blood Pressure compositions to help regulate blood pressure using naturally occurring food molecules.

Olfactive Biosolutions Protenx proprietary formulations use ingredients from the FDA’s Generally Recognized as Safe (GRAS) list. They are designed to be incorporated into existing ingredients or products, for example coffee or cookies, and so do not require consumers to change behavior.

Future Protenx Products
Our unique technology demonstrates how ectopic receptors often perform the same physiologic tasks as active pharmaceutical ingredients or APIs, and what ligands activate or inhibit them. These ligands can often be food molecules that humans have been ingesting for long periods of time.  Future Protenx products will:

●        Increase bronchodilation to potentially treat asthma and COPD

●        Reduce inflammation

●        Promote muscle regeneration

●        Increase bone remodeling

●        Increase sperm motility for more effective IVF

●    Reduce anxiety and treat depression by inducing the release of neurotransmitters such as dopamine and serotonin

The Company has been granted patents or has patents pending in the above areas.